References
Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987, 316: 178–82.
Kai H, Nose O, Iida Y, Ono J, Harada T, Yabuuchi H. Female pseudohermaphroditism caused by maternal congenital adrenal hyperplasia. J Pediatr 1979, 9: 418–20.
Lo JC, Schwitzgebel VM, Tyrrell JB, et al. Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999, 84: 930–6.
White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxilase deficiency. Endocr Rev 2000, 21: 245–91.
LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 2002, 87: 4048–53.
Alfaidy N, Li W, MacIntosh T, Yang K, Challis J. Late gestation increase in 11beta-hydroxysteroid dehydrogenase 1 expression in human fetal membranes: a novel intrauterine source of cortisol. J Clin Endocrinol Metab 2003, 88: 5033–8.
Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998, 129: 229–40.
Lindsay JR, Nieman LK. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 2005, 26: 775–99.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amadori, P. Reduced need of glucocorticoid therapy in a woman with congenital adrenal hyperplasia due to 21-hydroxylase deficiency during pregnancy. J Endocrinol Invest 29, 848–850 (2006). https://doi.org/10.1007/BF03347382
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347382